166 related articles for article (PubMed ID: 23499911)
1. AEG-1 overexpression is essential for maintenance of malignant state in human AML cells via up-regulation of Akt1 mediated by AURKA activation.
Long M; Hao M; Dong K; Shen J; Wang X; Lin F; Liu L; Wei J; Liang Y; Yang J; Gu F; Zhang H
Cell Signal; 2013 Jun; 25(6):1438-46. PubMed ID: 23499911
[TBL] [Abstract][Full Text] [Related]
2. Hyperforin inhibits Akt1 kinase activity and promotes caspase-mediated apoptosis involving Bad and Noxa activation in human myeloid tumor cells.
Merhi F; Tang R; Piedfer M; Mathieu J; Bombarda I; Zaher M; Kolb JP; Billard C; Bauvois B
PLoS One; 2011; 6(10):e25963. PubMed ID: 21998731
[TBL] [Abstract][Full Text] [Related]
3. Low expression of PTEN is essential for maintenance of a malignant state in human gastric adenocarcinoma via upregulation of p‑AURKA mediated by activation of AURKA.
Li L; Song Y; Liu Q; Liu X; Wang R; Kang C; Zhang Q
Int J Mol Med; 2018 Jun; 41(6):3629-3641. PubMed ID: 29512701
[TBL] [Abstract][Full Text] [Related]
4. AEG-1 promotes anoikis resistance and orientation chemotaxis in hepatocellular carcinoma cells.
Zhou Z; Deng H; Yan W; Luo M; Tu W; Xia Y; He J; Han P; Fu Y; Tian D
PLoS One; 2014; 9(6):e100372. PubMed ID: 24941119
[TBL] [Abstract][Full Text] [Related]
5. Expression of astrocyte elevated gene-1 (AEG-1) in human meningiomas and its roles in cell proliferation and survival.
Park KJ; Yu MO; Song NH; Kong DS; Park DH; Chae YS; Chung YG; Kang SH
J Neurooncol; 2015 Jan; 121(1):31-9. PubMed ID: 25182604
[TBL] [Abstract][Full Text] [Related]
6. Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells.
Zou Z; Yuan Z; Zhang Q; Long Z; Chen J; Tang Z; Zhu Y; Chen S; Xu J; Yan M; Wang J; Liu Q
Autophagy; 2012 Dec; 8(12):1798-810. PubMed ID: 23026799
[TBL] [Abstract][Full Text] [Related]
7. PTEN/AKT signaling mediates chemoresistance in refractory acute myeloid leukemia through enhanced glycolysis.
Ryu MJ; Han J; Kim SJ; Lee MJ; Ju X; Lee YL; Son JH; Cui J; Jang Y; Chung W; Song IC; Kweon GR; Heo JY
Oncol Rep; 2019 Nov; 42(5):2149-2158. PubMed ID: 31545464
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity.
Kikuno N; Shiina H; Urakami S; Kawamoto K; Hirata H; Tanaka Y; Place RF; Pookot D; Majid S; Igawa M; Dahiya R
Oncogene; 2007 Dec; 26(55):7647-55. PubMed ID: 17563745
[TBL] [Abstract][Full Text] [Related]
9. AEG-1 is a target of perifosine and is over-expressed in gastric dysplasia and cancers.
Huang W; Yang L; Liang S; Liu D; Chen X; Ma Z; Zhai S; Li P; Wang X
Dig Dis Sci; 2013 Oct; 58(10):2873-80. PubMed ID: 23912246
[TBL] [Abstract][Full Text] [Related]
10. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.
Nakamura S; Hirano I; Okinaka K; Takemura T; Yokota D; Ono T; Shigeno K; Shibata K; Fujisawa S; Ohnishi K
Carcinogenesis; 2010 Nov; 31(11):2012-21. PubMed ID: 20823107
[TBL] [Abstract][Full Text] [Related]
11. Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1.
Li J; Yang L; Song L; Xiong H; Wang L; Yan X; Yuan J; Wu J; Li M
Oncogene; 2009 Sep; 28(36):3188-96. PubMed ID: 19633686
[TBL] [Abstract][Full Text] [Related]
12. Aurora-A down-regulates IkappaBalpha via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival.
Yao JE; Yan M; Guan Z; Pan CB; Xia LP; Li CX; Wang LH; Long ZJ; Zhao Y; Li MW; Zheng FM; Xu J; Lin DJ; Liu Q
Mol Cancer; 2009 Nov; 8():95. PubMed ID: 19891769
[TBL] [Abstract][Full Text] [Related]
13. RNA interference-mediated knockdown of astrocyte elevated gene-1 inhibits growth, induces apoptosis, and increases the chemosensitivity to 5-fluorouracil in renal cancer Caki-1 cells.
Wang P; Yin B; Shan L; Zhang H; Cui J; Zhang M; Song Y
Mol Cells; 2014 Dec; 37(12):857-64. PubMed ID: 25431427
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte elevated gene-1 (AEG-1) shRNA sensitizes Huaier polysaccharide (HP)-induced anti-metastatic potency via inactivating downstream P13K/Akt pathway as well as augmenting cell-mediated immune response.
Zheng J; Li C; Wu X; Liu M; Sun X; Yang Y; Hao M; Sheng S; Sun Y; Zhang H; Long J; Liang Y; Hu C
Tumour Biol; 2014 May; 35(5):4219-24. PubMed ID: 24375254
[TBL] [Abstract][Full Text] [Related]
15. Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism.
Kelly KR; Nawrocki ST; Espitia CM; Zhang M; Yang JJ; Padmanabhan S; Ecsedy J; Giles FJ; Carew JS
Int J Cancer; 2012 Dec; 131(11):2693-703. PubMed ID: 22488249
[TBL] [Abstract][Full Text] [Related]
16. Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression.
Chiou JT; Chang LS
Apoptosis; 2024 Apr; 29(3-4):503-520. PubMed ID: 38066391
[TBL] [Abstract][Full Text] [Related]
17. Aurora kinase A controls meiosis I progression in mouse oocytes.
Saskova A; Solc P; Baran V; Kubelka M; Schultz RM; Motlik J
Cell Cycle; 2008 Aug; 7(15):2368-76. PubMed ID: 18677115
[TBL] [Abstract][Full Text] [Related]
18. Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.
den Hollander J; Rimpi S; Doherty JR; Rudelius M; Buck A; Hoellein A; Kremer M; Graf N; Scheerer M; Hall MA; Goga A; von Bubnoff N; Duyster J; Peschel C; Cleveland JL; Nilsson JA; Keller U
Blood; 2010 Sep; 116(9):1498-505. PubMed ID: 20519624
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells.
Zhu N; Gu L; Li F; Zhou M
Mol Cancer Ther; 2008 May; 7(5):1101-9. PubMed ID: 18483299
[TBL] [Abstract][Full Text] [Related]
20. The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells.
Sehdev V; Peng D; Soutto M; Washington MK; Revetta F; Ecsedy J; Zaika A; Rau TT; Schneider-Stock R; Belkhiri A; El-Rifai W
Mol Cancer Ther; 2012 Mar; 11(3):763-74. PubMed ID: 22302096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
